Express Pharma - Express Pharma

Numerous activities were conducted in over 64 Indian cities and around 10million diabetics were reached out through this campaign

Bags award for excellence in public relations programming in the employee communications category

To allow use of Potelligent CHOK1SV Cell Line for therapeutic antibody research and development

Organises community-based awareness activities with support from Bristol Myers Squibb Foundation at slum areas in Mumbai

Focuses on European market and setting up of a new R&D centre in Ahmedabad

Alleges that the real problem is infrastructure not availability of doctors

The upgrade will give Piramal two commercial grade ADC suites at the Grangemouth facility

In Q2' 13, the company posts consolidated revenues of Rs 228 crores

Zydus & IDRI will collaborate to conduct clinical development activities in India for visceral leishmaniasis (Kala-Azar)

Revenues at Rs 723 crores; EBITDA at Rs 175 crores; PAT at Rs 94 crores